Finance

Lists
FBIOP:NASDAQ
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
15,04 USD
+0,27%
(+0,040) 1D
5-ноя., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBIOP...
Open
15,08 USD
High
15,26 USD
Low
14,69 USD
Mkt. cap
61,37 млн
Avg. vol.
16,51 миң
Volume
6,74 миң
52-wk high
21,43 USD
52-wk low
6,27 USD
Beta
0,96
Shares outstanding
3,43 млн
No. of employees
78
Open
15,08 USD
High
15,26 USD
Low
14,69 USD
Mkt. cap
61,37 млн
Avg. vol.
16,51 миң
Volume
6,74 миң
52-wk high
21,43 USD
52-wk low
6,27 USD
Beta
0,96
Shares outstanding
3,43 млн
No. of employees
78
News stories
From web sources and news partners
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersБэй Харбор Айлендс, Флорида, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
17,63 млн
16,08 млн
16,04 млн
18,72 млн
Cost of goods sold
5,96 млн
5,07 млн
6,76 млн
6,95 млн
Cost of revenue
5,96 млн
5,07 млн
6,76 млн
6,95 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,42 млн
14,73 млн
15,89 млн
20,81 млн
Operating expense
18,48 млн
15,80 млн
17,02 млн
21,78 млн
Total operating expenses
24,44 млн
20,87 млн
23,78 млн
28,72 млн
Operating income
-6,81 млн
-4,79 млн
-7,74 млн
-10,01 млн
Other non operating income
32,74 млн
5,00 миң
152,83 млн
10,74 млн
EBT including unusual items
8,85 млн
-6,21 млн
142,29 млн
922,00 миң
EBT excluding unusual items
23,93 млн
-6,19 млн
142,29 млн
840,00 миң
Income tax expense
26,00 миң
-816,00 миң
5,13 млн
320,00 миң
Effective tax rate
0,29%
13,13%
3,61%
34,71%
Other operating expenses
-
-
-
-
Net income
5,85 млн
-3,94 млн
110,37 млн
-468,00 миң
Net profit margin
33,18%
-24,49%
688,20%
-2,50%
Earnings per share
-
-
-
-
Interest and investment income
736,00 миң
637,00 миң
570,00 миң
1,58 млн
Interest expense
-2,74 млн
-2,04 млн
-3,37 млн
-1,48 млн
Net interest expenses
-2,01 млн
-1,40 млн
-2,80 млн
105,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,65 млн
-3,63 млн
-6,52 млн
-8,94 млн
Gain or loss from assets sale
-
-
-
-82,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору